ADS-8901

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameADS-8901
Drug Alias NameTCAD therapy (Adamas)amantadine + ribavirin (Adamas)ADS-8901
ClassificationSmall molecules
Mechanisms of ActionNeuraminidase inhibitorsInosine-5'-monophosphate dehydrogenase (IMPDH) inhibitors
TargetsInosine-5'-monophosphate dehydrogenase (IMPDH)Neuraminidase
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAdamas Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdamas Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A